Patents by Inventor Cheng Zhang

Cheng Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100104746
    Abstract: Systems and methods for treating raw materials for formation into a wood product are provided. The raw materials may be, for example, strands, flakes, particles, wafers, or the like. In an embodiment, a first dispensing device dispenses a first liquid component onto raw materials within a chamber. A second dispensing device dispenses a second liquid component onto the raw materials. When the raw materials are mixed together, the first and second liquid components interact to form a bonding agent.
    Type: Application
    Filed: December 15, 2009
    Publication date: April 29, 2010
    Applicant: WEYERHAEUSER NR COMPANY
    Inventors: Jack G. Winterowd, Cheng Zhang, Erik M. Parker
  • Patent number: 7705015
    Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.
    Type: Grant
    Filed: March 11, 2009
    Date of Patent: April 27, 2010
    Assignee: Janssen Pharmaceutica, NV
    Inventors: Han-Cheng Zhang, Gee-Hong Kuo, Bruce E. Maryanoff, Hong Ye, David O'Neill, Lan Shen, David F. McComsey
  • Publication number: 20100092370
    Abstract: Powdered, amorphous carbon nanomaterials are formed from a carbon precursor in reverse microemulsion that includes organic solvent, surfactant and water. Methods for manufacturing amorphous, powdered carbon nanomaterials generally include steps of (1) forming a reverse microemulsion including at least one non-polar solvent, at least one surfactant, and at least one polar solvent, (2) adding at least one carbon precursor substance to the reverse microemulsion, (3) reacting the at least one carbon precursor substance so as to form an intermediate carbon nanomaterial, (4) separating the intermediate amorphous carbon nanomaterial from the reverse microemulsion, and (5) heating the intermediate amorphous carbon nanomaterial for a period of time so as to yield an amorphous, powdered carbon nanomaterial.
    Type: Application
    Filed: October 10, 2008
    Publication date: April 15, 2010
    Applicant: HEADWATERS TECHNOLOGY INNOVATION, LLC
    Inventors: Cheng Zhang, Bing Zhou
  • Patent number: 7670588
    Abstract: Hydrogen is stored by adsorbing the hydrogen to a carbon nanomaterial that includes carbon nanospheres. The carbon nanospheres are multi-walled, hollow carbon nanostructures with a maximum diameter in a range from about 10 nm to about 200 nm. The nanospheres have an irregular outer surface and an aspect ratio of less than 3:1. The carbon nanospheres can store hydrogen in quantities of at least 1.0% by weight.
    Type: Grant
    Filed: September 5, 2007
    Date of Patent: March 2, 2010
    Assignee: Headwaters Technology Innovation, LLC
    Inventors: Bing Zhou, Cheng Zhang
  • Patent number: 7666915
    Abstract: The particle sizes of agglomerates of carbon nanospheres are reduced by dispersing the carbon nanospheres in a polar solvent. The carbon nanospheres are multi-walled, hollow, graphitic structures with an average diameter in a range from about 10 nm to about 200 nm, more preferably about 20 nm to about 100 nm. Spectral data shows that prior to being dispersed, the carbon nanospheres are agglomerated into clusters that range in size from 500 nm to 5 microns. The clusters of nanospheres are reduced in size by dispersing the carbon nanospheres in the polar solvent (e.g., water) using a surface modifying agent (e.g., glucose) and ultrasonication. The combination of polar solvent, surface modifying agent, and ultrasonication breaks up and disperses agglomerates of carbon nanospheres.
    Type: Grant
    Filed: September 24, 2007
    Date of Patent: February 23, 2010
    Assignee: Headwaters Technology Innovation, LLC
    Inventors: Cheng Zhang, Bing Zhou
  • Publication number: 20100038263
    Abstract: Hydrogen is stored by adsorbing the hydrogen to a carbon nanomaterial that includes carbon nanospheres. The carbon nanospheres are multi-walled, hollow carbon nanostructures with a maximum diameter in a range from about 10 nm to about 200 nm. The nanospheres have an irregular outer surface with graphitic defects and an aspect ratio of less than 3:1. The carbon nanospheres can store hydrogen in quantities of at least 1.0% by weight.
    Type: Application
    Filed: October 22, 2009
    Publication date: February 18, 2010
    Applicant: HEADWATERS TECHNOLOGY INNOVATION, LLC
    Inventors: Bing Zhou, Cheng Zhang
  • Patent number: 7652253
    Abstract: A method of analyzing a remotely-located object includes the step of illuminating at least a portion of a targeted object with electromagnetic radiation to induce a phase transformation in the targeted object, wherein the phase transformation produces an emitter plasma, which emits terahertz radiation. The method also includes the step of ionizing a volume of an ambient gas to produce a sensor plasma by focusing an optical probe beam in the volume and the step of detecting an optical component of resultant radiation produced from an interaction of the focused optical probe beam and the terahertz radiation in the sensor plasma. Detecting an optical component of the resultant radiation emitted by the sensor plasma facilitates detection of a characteristic fingerprint of the targeted object imposed onto the terahertz radiation produced as a result of the induced phase transformation.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: January 26, 2010
    Assignee: Rensselaer Polytechnic Institute
    Inventors: Xi-Cheng Zhang, Jianming Dai, Xu Xie
  • Patent number: 7650185
    Abstract: A system and method for waking up an implantable medical device (“IMD”) from a sleep state in which power consumption by the IMD is essentially zero. The IMD may be adapted to perform one or more designated measurement and/or therapeutic functions. In one embodiment, the IMD includes a wake-up sensor that is adapted to sense the presence or absence of a wake-up field generated by another IMD or an external device. The wake-up field may, in some embodiments, be an electromagnetic field, a magnetic field, or a physiologically sub-threshold excitation current (i.e., E-field). Upon sensing by the wake-up sensor of the wake-up field, other components of the IMD, which may include a controller, a sensing and/or therapy module, and/or a communications module, are awakened to perform one or more designated functions.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: January 19, 2010
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Keith R. Maile, Abhijeet V. Chavan, Von Arx A. Jeffrey, Cheng Zhang
  • Publication number: 20100010559
    Abstract: A remaining charge capacity of a battery having an initial charge capacity is monitored. The battery powers a remote implantable medical device (IMD) that includes an active state, during which the remote IMD performs at least one function, and an inactive state, during which the remote IMD performs no functions. An active state charge consumption is computed based on stored parameters associated with an operational charge consumption for each function, and an inactive state charge consumption is computed based on a leakage current associated with the inactive state and a time the remote IMD is in the inactive state. The active state charge consumption and inactive state charge consumption are subtracted from the initial charge capacity to determine the remaining charge capacity.
    Type: Application
    Filed: June 26, 2009
    Publication date: January 14, 2010
    Inventors: Cheng ZHANG, Keith R. Maile
  • Patent number: 7632774
    Abstract: Supported catalysts include an inorganic solid support such as silica that is functionalized to have inorganic acid functional groups attached thereto. The functionalization of the support material is optimized by (i) limiting the amount of water present during the functionalization reaction, (ii) using a concentrated mineral acid or derivative thereof, and/or (iii) increasing the reaction temperature and/or reaction pressure. The acid-functionalized support material serves as a support for a metal nanoparticle catalyst. The nanocatalyst particles are preferably bonded to the support material through an organic molecule, oligomer, or polymer having functional groups that can bind to both the nanocatalyst particles and to the support material. The supported catalysts can advantageously be used for the direct synthesis of hydrogen peroxide from hydrogen and oxygen feed streams.
    Type: Grant
    Filed: March 30, 2006
    Date of Patent: December 15, 2009
    Assignee: Headwaters Technology Innovation, LLC
    Inventors: Michael A. Rueter, Sukesh Parasher, Cheng Zhang, Bing Zhou
  • Patent number: 7629319
    Abstract: The invention is directed to novel heteroaryl peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis and related disorders, cancer, and neurodegenerative disorders. Pharmaceutical compositions comprising the substituted heteroaryl peptidomimetics of the present invention and methods of treating conditions mediated by the thrombin receptor are also disclosed.
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: December 8, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Han-Cheng Zhang, Bruce E. Maryanoff, William J. Hoekstra, Kimberly White
  • Patent number: 7617743
    Abstract: Disclosed are a device and a method for distributing measurement sample and cleaning tubes. The device comprises a diluent container for accommodating a diluent therein; an aspirating tube for sucking a measurement sample; a first syringe for quantifying the measurement sample; a second syringe for quantifying the diluent; a first switching unit for switching between a first passage and a second passage; a bath; a sample buffer tube communicated with the first syringe; a dispensing tube for dispensing the measurement sample or the diluent into the bath; a second switching unit for switching between a third passage and a fourth passage. A reagent buffer tube, a reagent container and a third switching unit may be further provided between the sample buffer tube and the first syringe, or between the second switching unit and the input port of the dispensing tube.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: November 17, 2009
    Assignee: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    Inventors: Yaohui Zhang, Cheng Zhang
  • Patent number: 7618945
    Abstract: The invention is directed to novel heteroaryl peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis and related disorders, cancer, and neurodegenerative disorders. Pharmaceutical compositions comprising the substituted heteroaryl peptidomimetics of the present invention and methods of treating conditions mediated by the thrombin receptor are also disclosed.
    Type: Grant
    Filed: September 15, 2005
    Date of Patent: November 17, 2009
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Han-Cheng Zhang, Bruce E. Maryanoff, William J. Hoekstra, Kimberly White
  • Patent number: 7608634
    Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
    Type: Grant
    Filed: May 8, 2007
    Date of Patent: October 27, 2009
    Assignee: Janssen Pharmaceutica NV
    Inventors: Han-Cheng Zhang, Bruce E. Maryanoff, David F. McComsey, Kimberly White, Hong Ye, Leonard R. Hecker, Bruce Conway, Keith Demarest
  • Patent number: 7607363
    Abstract: The present invention discloses a liquid volumetric device comprising a metering tube, a start sensor, an end sensor, a bath for storage of a sample to be metered, a vacuum chamber and a pump for pumping out air inside the vacuum chamber to form a negative pressure inside the vacuum chamber. The start sensor and the end sensor are provided respectively at the bottom and the top of the metering tube, the top of the metering tube is in communication respectively with the vacuum chamber and the outside atmosphere via pipelines, the bottom of the metering tube is in communication respectively with the bath and the vacuum chamber via pipelines, and control parts are provided in each of the pipelines for controlling connection/disconnection thereof.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: October 27, 2009
    Assignee: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    Inventors: Yaohui Zhang, Cheng Zhang, Liangqing Li
  • Patent number: 7601668
    Abstract: Improved bi-metallic nanocatalysts are manufactured using a control agent to produce nanoparticles having a controlled crystal face exposure. The bi-metallic nanocatalyst particles are manufactured in a two-step process. In a first step, nanocatalyst particles are manufactured using the control agent and the primary metal atoms. The primary metal atoms and the control agent are reacted to form complexed metal atoms. The complexed metal atoms are then allowed or caused to form nanoparticles. The nanoparticles formed in the first step using the control agent have a desired crystal face exposure. In a second step, the secondary metal atoms are deposited on the surface of the primary metal nanoparticles. The secondary catalyst atoms maintain the same crystal face exposure as the primary metal nanoparticles.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: October 13, 2009
    Assignee: Headwaters Technology Innovation, LLC
    Inventors: Zhenhua Zhou, Zhihua Wu, Cheng Zhang, Bing Zhou
  • Patent number: 7595491
    Abstract: A method for generating terahertz radiation includes inducing a background plasma in a volume of a gas by focusing a first optical beam in the volume, and generating pulsed terahertz radiation with enhanced generation efficiency by focusing a second time-delayed optical beam in the background plasma. The method may be implemented in a system for detecting and analyzing a remotely-located object.
    Type: Grant
    Filed: May 31, 2007
    Date of Patent: September 29, 2009
    Assignee: Rensselaer Polytechnic Institute
    Inventors: Xi-Cheng Zhang, Jianming Dai, Xu Xie
  • Publication number: 20090228903
    Abstract: The present invention is directed to an apparatus, system, methods, and computer-program product for sending a data event so that a work flow event can be correlated with a data event. According to one embodiment of the invention, a data event sending apparatus can be provided. The apparatus can include a receiver for receiving data revised by a node from which a work flow event is emitted, a formatter for obtaining correlation information on the work flow event according to predefined logic for the revised data, and for formatting the revised data and the correlation information to obtain a data event, and a sender for sending the data event.
    Type: Application
    Filed: February 27, 2009
    Publication date: September 10, 2009
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Yi Che, Yan Zhou, Cheng Zhang
  • Patent number: 7570998
    Abstract: An implantable medical device is adapted for implantation into body tissue. The implantable medical device comprises a housing and a header coupled to the housing. A cavity is located in the header. An ultrasonic transducer adapted to transmit acoustic waves at a communication frequency is located in the cavity, and a coupling surface is interposed between the ultrasonic transducer and the body tissue and is acoustically coupled with the body tissue.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: August 4, 2009
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Cheng Zhang, Thomas W. Piaget, Abhijeet V. Chavan, Keith R. Maile, Ron A. Balczewski
  • Patent number: 7566722
    Abstract: The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof: wherein R1 and R2 are as defined herein, and their methods of preparation and use as ADP inhibitors.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: July 28, 2009
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Han-Cheng Zhang, Bruce E. Maryanoff, Hong Ye, Cailin Chen